DXP reductoisomerase
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='3zhy' size='340' side='right' caption='DXP reductoisomerase complex with NADPH, Mn+2 ion and anti-malaria drug fosmidomycin (PDB code 3zhy)' scene=''> '''DXP ...) |
|||
| Line 1: | Line 1: | ||
| - | |||
<StructureSection load='3zhy' size='340' side='right' caption='DXP reductoisomerase complex with NADPH, Mn+2 ion and anti-malaria drug fosmidomycin (PDB code [[3zhy]])' scene=''> | <StructureSection load='3zhy' size='340' side='right' caption='DXP reductoisomerase complex with NADPH, Mn+2 ion and anti-malaria drug fosmidomycin (PDB code [[3zhy]])' scene=''> | ||
| - | '''DXP reductoisomerase''' (DXR) or '''1-deoxy-D-xylulose-5-phosphate reductoisomerase''' or '''IspC''' catalyzes the conversion of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate. DXR is part of the nonmevalonate pathway which synthesizes isoprenoids which are essential components of bacterial cell wall. NADPH is a cofactor of the reaction. Divalent metal cations (Mg+2, Mn+2) are involved in binding of the DXP substrate to DXR. | + | '''DXP reductoisomerase''' (DXR) or '''1-deoxy-D-xylulose-5-phosphate reductoisomerase''' or '''IspC''' catalyzes the conversion of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate. DXR is part of the nonmevalonate pathway which synthesizes isoprenoids which are essential components of bacterial cell wall. NADPH is a cofactor of the reaction. Divalent metal cations (Mg+2, Mn+2) are involved in binding of the DXP substrate to DXR.<ref>PMID:9707569</ref> |
== Function == | == Function == | ||
Revision as of 10:21, 11 January 2016
| |||||||||||
3D Structures of DXP reductoisomerase
Updated on 11-January-2016
References
- ↑ Takahashi S, Kuzuyama T, Watanabe H, Seto H. A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9879-84. PMID:9707569
